SuperworthIradimed shares outstanding IRMD
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 12.9M
- On a year earlier
- +0.3%
- more shares
Iradimed had 12.9M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 12.9M | +0% |
| FY2024 | 12.8M | +1% |
| FY2023 | 12.7M | +1% |
| FY2022 | 12.6M | −0% |
| FY2021 | 12.6M | +1% |
| FY2020 | 12.5M | +1% |
| FY2019 | 12.4M | +1% |
| FY2018 | 12.3M | +4% |
| FY2017 | 11.7M | −0% |
| FY2016 | 11.8M | −12% |
| FY2015 | 13.3M | +13% |
| FY2014 | 11.8M | +34% |
| FY2013 | 8.8M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 12.9M | +0% | |
| Q1 FY26 | 12.9M | +0% | |
| Q4 FY25 | 12.9M | +0% | |
| Q3 FY25 | 12.9M | +1% | |
| Q2 FY25 | 12.8M | +1% | |
| Q1 FY25 | 12.8M | +1% | |
| Q4 FY24 | 12.8M | +1% | |
| Q3 FY24 | 12.8M | +0% | |
| Q2 FY24 | 12.8M | +0% | |
| Q1 FY24 | 12.7M | +0% | |
| Q4 FY23 | 12.7M | +1% | |
| Q3 FY23 | 12.7M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Iradimed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.